patient access

Patients

The hidden access gap in Europe’s lung cancer hospital data

New hospital-level analysis shows a provider landscape that is more concentrated, regionally uneven & strategically complex than commercially assumed.

Market Access

Beyond the Bill: how do we make medicines affordable without...

Two pharmaceutical giants have paused investment in the UK. More than a setback for British life sciences, it’s a warning sign for the future.

R&D

pharmaphorum podcast Episode 207a, Brandon Pence

The importance of being disruption ready, with Brandon Pence

Brandon Pence, recently appointed President and COO of Fujifilm Biosciences, discusses the cell culture media industry and being disruption ready.

Patients

Frontiers Health limited series podcast, Roberta Sarno

FH25: On patient access and equity, with Roberta Sarno

In another episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with founder, director, and global health advisor.

Patients

Do we need to rethink the role of private healthcare in pati...

Timely patient access to medication has become an acute problem in the UK healthcare system, with patients often caught in a tug-of-war between an overburdened NHS and the high costs of tra

Market Access